Enter your Email address:
Wolters Kluwer Health may email you for journal alerts and information, but is committed
to maintaining your privacy and will not share your personal information without
You currently have no recent searches
Cohen, Myron S MD
Institute of Global Health and Infectious Diseases The University of North Carolina at Chapel Hill Chapel Hill, NC
To the Editors:
Antiretroviral therapy (ART) certainly has the potential to reduce HIV transmission, and the use of treatment as prevention is highly desirable.1 But the magnitude and durabilty of benefit of ART for prevention are unknown, and the provocative observational2 and ecological studies3,4 cited in Dr Montaner's and Hogg's correspondence do not offer such insight. We need to address 2 crucial issues as follows: (1) How should we advise HIV discordant couples about their transmission risk when the infected partner is receiving ART? (2) How do we develop a “test and treat” strategy" that reliably reduces incident cases of HIV.
Dr Wang Lu's article5 is important because it reflects on both of the above questions in the real world, not as the result of a controlled study or a modeling exercise. Her detection of HIV transmission from people provided ART does not negate the idea that lowering the viral load could reduce the per-contact probability of an HIV transmission event6; this is not an idea in dispute. But in the real world-for many reasons-people do not always experience continued and reliable suppression of HIV with ART (even in China where treatment and care are free). In the real world, people cannot monitor their viral load and STDs before sexual encounters; and suppression of HIV in blood frequently fails to prevent HIV replication and shedding in the genital tract.7
The success of the “test and treat strategy” requires that ART provided under real-world conditions-like in rural China or rural Africa-reliably and durably prevent transmission of HIV with reduction in new cases of HIV; Dr Wang Lu report highlights the obvious challenges we face as we try to harness ART as an HIV prevention modality.
Myron S. Cohen, MD
This article has been cited 1 time(s).
© 2011 Lippincott Williams & Wilkins, Inc.
Colleague's E-mail is Invalid
Your Name: (optional)
Separate multiple e-mails with a (;).
Thought you might appreciate this item(s) I saw at JAIDS Journal of Acquired Immune Deficiency Syndromes.
Send a copy to your email
Your message has been successfully sent to your colleague.
Some error has occurred while processing your request. Please try after some time.
An Existing Folder
A New Folder
The item(s) has been successfully added to "".
Login with your LWW Journals username and password.
Username or Email:
Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.
Link to reset your password has been sent to specified email address.
What does "Remember me" mean?
By checking this box, you'll stay logged in until you logout. You'll get easier access to your articles, collections,
media, and all your other content, even if you close your browser or shut down your
To protect your most sensitive data and activities (like changing your password),
we'll ask you to re-enter your password when you access these services.
What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend
that you uncheck the "Remember me" box.
Save my selection
Article Level Metrics